ArticleInfectious diseases and therapy2023

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults.

Guiling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.